CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

News and Events

Latest News

Consultations Help Shape Updated Patient Input Guide

December 3, 2020
Feedback from more than 35 patient groups has helped CADTH update its Guidance for Providing Patient Input — a key resource for patient groups, patients, and caregivers who contribute to our reimbursement review process. The guide now addresses some of the key improvements suggested by patient groups, which include: expanding the definition ...

CADTH Recommends First Gene Therapy Treatment for Rare Form of Childhood Vision Loss

November 26, 2020
Voretigene neparvovec (Luxturna) is the first gene therapy evaluated through the CADTH reimbursement review process CADTH recommends reimbursement with conditions, including a price reduction, and offers advice on implementing the recommendation On November 16, CADTH recommended that Canada’s federal, provincial, and territorial drug pla...

2020 Virtual CADTH Symposium - New Content Available

November 25, 2020
Did you miss some of the great live sessions during the 2020 Virtual CADTH Symposium? Great news — our plenary and concurrent sessions are now available for on-demand viewing on the Symposium website. In more great news, we’ve added 30 new pre-recorded sessions that will bring you fresh insights on a range of topics, including: Artificial i...

Upcoming Events

There’s Always Evidence…

January 19, 2021 - February 9, 2021
There’s solid agreement that decisions in health care that are informed by hard facts are likely to be better than decisions made based on gut instinct or something your brother’s best friend’s second cousin says his grandmother’s neighbour told him. Systematic reviews and meta-analyses are regarded as the gold standard for evidence, but they ar...

How CADTH Expert Committees Deliberate

February 4, 2021
CADTH has three expert committees that provide recommendations to publicly funded drug programs, health ministries, and health authorities on the appropriate use of drugs, medical devices, and clinical interventions: CADTH pan-Canadian Oncology Drug Review Expert Review Committee (pERC): cancer drugs CADTH Canadian Drug Expert Committee (CDE...

Consultation for Patients on the Deliberative Appraisal Process at CADTH

February 11, 2021
The top three principles for the deliberative process identified by the Health Technology Assessment International 2020 Global Policy Forum were transparency, inclusivity, and impartiality. CADTH has worked with a few patient groups to create a two-part consultation to support wide participation: first, an education session — How CADTH Expert C...